Gynecologic Cancer
Conference Coverage
Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costs
The Affordable Care Act did not spare many gynecologic cancer patients from financial hardship.
Conference Coverage
Frail status may be better than age for predicting ovarian cancer outcomes
Conference Coverage
Cytoreduction in advanced ovarian cancer: ‘Keep the status quo’
Debulking surgery should be considered whenever feasible, according to researchers.
Conference Coverage
Study: Gynecologic cancer therapy does not increase COVID-19 risks
Conference Coverage
Intervention reduced racial disparities among patients in cancer trials
A navigation program improved outcomes of Black women with endometrial cancer enrolled in clinical trials.
Conference Coverage
Delaying surgery didn’t impact survival in early-stage cervical cancer
The results are “reassuring” in light of the pandemic, according to an investigator.
Conference Coverage
Rucaparib extends PFS in BRCA-mutated ovarian cancer, with an exception
The PARP inhibitor was superior to chemotherapy, except in patients with BRCA reversion mutations.
From the Journals
Is the WHO’s HPV vaccination target within reach?
The WHO’s goal is to have HPV vaccines delivered to 90% of all adolescent girls by 2030.
From the Journals
SNP chips deemed ‘extremely unreliable’ for identifying rare variants
Single-nucleotide polymorphism chips are more likely to be wrong than right when it comes to rare variants, researchers say.
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Conference Coverage
Vaginal pH may predict CIN 2 progression in HIV-positive women